The largest database of trusted experimental protocols

5 protocols using palmitic acid

1

Lipid and Compound Preparation for Biophysical Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
1,2-Dimyristoyl-sn-glycero-3-phosphocholine
(DMPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC), and 1,2-dipalmitoyl-sn-glycero-3-phospho-l-serine (DPPS, sodium salt) powders were purchased from Avanti
Polar Lipids (purity certified by the supplier >99%), whereas palmitic
acid (PA), stearic acid (SA), oleic acid (OA), elaidic acid (EA),
linoleic acid (LA), and docosahexaenoic acid (DHA), as well as nisin
(lyophilized powder containing ∼2.5% w/w nisin), solvents,
and the other chemicals were obtained from Sigma-Aldrich. The lipids
were of the highest available purity (≥99%) and were used without
further purification. All solvents were of analytical grade.
+ Open protocol
+ Expand
2

Lipidomics Analysis of Fatty Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 2,5-dihydroxybenzoic acid matrix was purchased from Bruker Daltonics (Bremen, Germany). Human angiotensin II and human bradykinin fragments 1 to 7 were purchased from Sigma-Aldrich (St Louis, MO). The standard fatty acids palmitic acid and stearic acid were purchased from Avanti Polar Lipids (Birmingham, AL). Hexane, methanol, and ultra-pure water were purchased from Wako Pure Chemical (Osaka, Japan). Highly purified EPA ethyl ester (EPA-E; purity, >97%) and highly purified DHA ethyl ester (DHA-E; purity, >98%) were obtained from Nippon Suisan Kaisha, Ltd (Tokyo, Japan) and Harima Food Inc (Kakogawa, Japan), respectively.
+ Open protocol
+ Expand
3

Fatty Acid Modulation of PBMC Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated by centrifugation over Ficoll-Hypaque, and cultured in RPMI 1640 supplemented with 10% autologous serum. Palmitic acid (16:0), stearic acid (18:0), and soy-derived lysophosphatidylcholine (LPCsoy) (Avanti Polar Lipids) were dissolved in 100% ethanol and filter-sterilized (10 mM stock solutions). The fatty acids, or ethanol (EtOH) vehicle control, were added (10 μM final concentration) to fresh RPMI 1640 supplemented with 5% autologous serum, and incubated for 30 min prior to stimulation of PBMCs. Cells were stimulated for 24 h with prepared fatty acid containing media, with or without LPS (100 ng/mL) (Invivogen).
For the whole blood stimulation experiments, blood (1 mL) was incubated in 15-mL conical tubes (BD Biosciences) for 3 h with individual fatty acids (10 μM final concentration for all) or ethanol vehicle control. Blood samples were then incubated for 15 min on ice with FACS Lysis buffer (BD Biosciences), and washed with flow wash buffer in preparation for analysis by flow cytometry.
+ Open protocol
+ Expand
4

Lipidomics Standards Acquisition Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All lipid standards were purchased from Avanti Polar Lipids except for triacylglycerol (TG) 15:0_15:0_15:0, lyso-phosphatidylcholine (LPC) O-16:0, LPC O-18:0 and palmitic acid. TG 15:0_15:0_15:0 and palmitic acid were obtained from Sigma-Aldrich. DG 18:2_22:6 and TG 12:0_18:2_22:6 were synthesized using a method described by Halldorsson et al. [23 (link)], as detailed in Additional file 1: Methods. LPC O-16:0 and LPC O-18:0 were purchased from Cayman Chemical (Michigan, USA) and diluted in phosphate-buffered saline (PBS) at a stock concentration of 5 mmol/l prior to the analysis. palmitic acid was dissolved in ethanol at a stock concentration of 20 mmol/l. DG 18:2_22:6 and TG 12:0_18:2_22:6 were dissolved in dimethyl sulfoxide at a stock concentration of 20 mmol/l.
+ Open protocol
+ Expand
5

Palmitic Acid Toxicity in Hypoxia

Check if the same lab product or an alternative is used in the 5 most similar protocols
To load BSA with palmitic acid, ultra-fatty acid free BSA (Sigma-Aldrich) was dissolved in 150 mM NaCl at 37°C to a 0.34 mM concentration and filtered. palmitic acid (Avanti Polar Lipids, Alabaster, AL) was dispersed in 150 mM NaCl with stirring at 70°C for 30 minutes to a 2 mM concentration. Equal volumes of each solution were mixed together, stirred at 37°C for 1 hour and pH was adjusted to 7.4. Aliquots of this stock solution containing 1 mM palmitic acid / 0.17 mM BSA were stored in dark glass vials at -20°C. Identically prepared and stored FA-free 0.17 mM BSA solution was used as the control. To assess toxicity, neuroblastoma cell lines were grown overnight in 96-well plates to ~50% confluency in RPMI media supplemented with 5% FBS. palmitic acid loaded onto BSA and BSA control were added to a final concentration of 0 - 200 uM. Cells were incubated for 24 hours under either normoxic or hypoxic conditions. For hypoxia, cells were incubated in a hypoxia chamber (COY Laboratory Products, Grass Lake, MI) at 1% oxygen. Cell apoptosis was assessed by measuring activity of caspase-3 using Caspase-3 DEVD-R110 Fluorometric HTS Assay Kit (Biotium, Hayward, CA) as recommended by the manufacturer. Readings were obtained via Gen 5 software on a Synergy 2 plate reader (BioTek, Winooski, VT). Each concentration was tested in triplicate in at least three independent experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!